Libros bestsellers hasta 50% dcto  Ver más

menu

0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional
portada contemporary research on renal cell carcinoma: basic and clinical developments (in English)
Type
Physical Book
Publisher
Year
2011
Language
English
Pages
158
Format
Paperback
Dimensions
23.4 x 15.6 x 1.0 cm
Weight
0.25 kg.
ISBN
3642786111
ISBN13
9783642786112

contemporary research on renal cell carcinoma: basic and clinical developments (in English)

Gerd Staehler (Illustrated by) · Sigmund Pomer (Illustrated by) · Springer · Paperback

contemporary research on renal cell carcinoma: basic and clinical developments (in English) - Staehler, Gerd ; Pomer, Sigmund

Physical Book

$ 104.20

$ 109.99

You save: $ 5.79

5% discount
  • Condition: New
It will be shipped from our warehouse between Monday, May 20 and Tuesday, May 21.
You will receive it anywhere in United States between 1 and 3 business days after shipment.

Synopsis "contemporary research on renal cell carcinoma: basic and clinical developments (in English)"

The management of advanced renal cell carcinoma is still problematic. Surgery, although the therapy of choice for locally advanced renal tumors, is still controversial as the treatment for metastases. The role of surgery in the management of patients with pulmonary, bony, and liver metastasis is one of the subject matters discussed in this book. Our results with series of patients undergoing resection of metastases from the lung, bone, and liver show that surgery may be appropriate in selected patients with a good performance status, although most of them certainly cannot be cured by this procedure alone, i.e., in the absence of effective adjuvant therapies. As recent developments show, new strategies for immunotherapy of renal cell carcinoma represent a modest advance over traditional approaches in the treatment of this cancer, such as chemo- and radiotherapy. Clinical trials employing recombinant interferon-a and interleukin 2 produced response rates in up to 30% of patients treated, as evidenced by the European Immunotherapy Trials Program. The adverse reactions and the lack of efficacy in the majority of patients warrants the search for new immunotherapeutic approaches.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews